This study demonstrated that recurrent clones are regulated via the hepatocyte growth factor (HGF)-cMet signaling pathway and are characterized by high expression of the putative HNSCC CSC marker CD10 [98]. The gene discussed is HGF; the disease is head and neck squamous cell carcinoma.